Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular

Shilpa Bhatia1, Nimrah A Baig2, Olga Timofeeva2

  • 1Department of Radiation Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.

Oncotarget
|April 17, 2015
PubMed

Insights

EphB1 receptor tyrosine kinase is dysregulated in medulloblastomas. Downregulating EphB1 inhibits tumor growth, migration, and enhances radiosensitivity, identifying it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Eph family receptor tyrosine kinases and ephrin ligands are often dysregulated in medulloblastomas.
  • EphB1's specific role in medulloblastoma pathogenesis and treatment response is not fully understood.

Purpose of the Study:

  • To investigate the expression and functional significance of EphB1 in medulloblastoma.
  • To evaluate EphB1 as a potential therapeutic target for medulloblastoma.

Main Methods:

  • Assessed EphB1 mRNA and protein expression in medulloblastoma cell lines (DAOY, UW228).
  • Utilized EphB1 knockdown and genetic loss models in cell lines and engineered mouse models.
  • Analyzed effects on cell growth, viability, cell cycle, migration, and radiosensitivity.

Main Results:

  • EphB1 is expressed in medulloblastoma cell lines.
  • EphB1 downregulation reduced cell growth, viability, and migration, while increasing G1 cell cycle arrest.
  • EphB1 knockdown enhanced radiosensitivity and delayed tumor recurrence in mouse models.

Conclusions:

  • EphB1 plays a critical role in medulloblastoma progression and radiation response.
  • Targeting EphB1 presents a promising therapeutic strategy for medulloblastoma treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K